The ALPS Alerian Energy Infrastructure ETF (ENFR) garners a "Buy" rating, offering investors diversified exposure to the U.S. oil and gas midstream sector. This ETF is poised to benefit from increasing domestic electricity demand fueled by data center expansion and reindustrialization, alongside global gas supply disruptions. With a 4.23% yield, consistent distribution growth since 2022, and low expenses (35bps), ENFR provides robust cash flow for both income generation and reinvestment. While sector concentration and potential leverage increases pose risks, ENFR remains a valuable component for a diversified portfolio.

Conestoga Capital's Q1 2026 small-cap portfolio commentary reveals a period of mixed performance, with some companies exceeding expectations while others faced challenges. The firm remains committed to its core strategy of investing in high-quality businesses with strong underlying fundamentals, despite short-term market fluctuations. Key highlights include growth in aerospace and defense sectors, and strategic exits from underperforming assets.

Conestoga Capital's Small Cap Composite experienced a -5.01% net-of-fees return in Q1 2026, trailing the Russell 2000 Growth Index's -2.81%. The underperformance was primarily driven by negative stock selection in the Technology sector, particularly software stocks, which faced valuation compression. Conversely, strong stock selection in the Industrials sector provided a positive contribution, highlighting the resilience of companies with robust backlogs and clear earnings visibility amidst challenging market conditions.

The run rate is a financial metric used to predict a company's future performance by annualizing current financial data. While useful for new companies or those undergoing changes, it can be misleading in seasonal industries or when influenced by one-time events. This article explores its applications, benefits, and potential pitfalls for accurate business forecasting.

Northrop Grumman's stock, trading significantly below its intrinsic value after a 16% decline, has been upgraded to a Strong Buy. Despite beating Q1 2026 estimates with double-digit organic sales growth, margin expansion remains limited due to development and ramp-up phases. The company's 2026 guidance remains stable, projecting sales of $43.5-$44 billion and EPS of $27.40-$27.90. A base case price target of $711.67 suggests a 21% upside, supported by its valuation and long-term outlook.